Hence then, the article about ardelyx provides update on fda appeal for xphozah tenapanor for the control of serum phosphorus in adult patients with chronic kidney disease on dialysis was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Ardelyx Provides Update on FDA Appeal for XPHOZAH® (tenapanor) for the Control of Serum Phosphorus in Adult Patients with Chronic Kidney Disease on Dialysis )
Last updated :
Also on site :
- Babar Azam likely to be named as Pakistan Test captain: Reports
- DoE Deletes Webpage Instructing People To Lower Thermostat to 78
- Former Vikings Guard Jim Battle Dies at 88